Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

HEPMET-1: Evaluate the Feasibility, Mental Sideeffects and the Efficacy of Hepatitis C Treatment in a Methadone Maintenance Treated (MMT) Opioid Addicted Group.

NCT00147784 is registered in ClinicalTrials.gov with Sorlandet Hospital HF as lead sponsor.

NCT NCT00147784
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00147784 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
HEPMET-1: Evaluate the Feasibility, Mental Sideeffects and the Efficacy of Hepatitis C Treatment in a Methadone Maintenance Treated (MMT) Opioid Addicted Group.
Lead sponsor
Sorlandet Hospital HF
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2006
Completion date
January 31, 2008
Enrollment
10 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis, opiate dependence